WG
RCUS icon

Winton Group’s Arcus Biosciences RCUS Stock Holding History

Winton Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$709K Sell
32,820
-29,431
-47% -$636K 0.02% 621
2025
Q4 		$1.48M Sell
62,251
-29,978
-33% -$612K 0.05% 342
2025
Q3 		$1.25M Buy
+92,229
New +$959K 0.05% 369
2025
Q2 		– Sell
-115,595
Closed -$907K – 976
2025
Q1 		$907K Buy
115,595
+43,285
+60% +$502K 0.06% 443
2024
Q4 		$1.08M Buy
72,310
+3,730
+5% +$60.9K 0.07% 297
2024
Q3 		$1.05M Buy
68,580
+9,443
+16% +$149K 0.07% 297
2024
Q2 		$901K Buy
59,137
+1,872
+3% +$30.2K 0.06% 321
2024
Q1 		$1.08M Buy
+57,265
New +$990K 0.08% 225
2022
Q1 		– Sell
-6,910
Closed -$280K – 1116
2021
Q4 		$280K Buy
+6,910
New +$268K 0.02% 855

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Winton Group's RCUS Position: Q1 2026 in Review

Winton Group reduced its Arcus Biosciences (RCUS) stake by 47% in Q1 2026, selling an estimated $636K and leaving 32,820 shares worth $709K. The position accounts for 0.02% of the portfolio, ranked #621.

Winton Group first reported a position in RCUS in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.48M in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Winton Group held 32,820 shares of Arcus Biosciences worth $709K as of Q1 2026.
  • Winton Group sold 29,431 Arcus Biosciences shares in Q1 2026, an estimated $636K.
  • Arcus Biosciences made up 0.02% of Winton Group's portfolio in Q1 2026, its #621 holding.
  • Winton Group first reported a position in Arcus Biosciences in Q4 2021 and has held it in 9 quarters since.
  • Winton Group's Arcus Biosciences position peaked at $1.48M in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.